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TheU.S. EnvironmentalProtectionAgency'sGene-¶bK Programisamultiphasedefforttoreviewandevaluatetheex-
istinglteratre inassaysysemsavilableinthefieldofgenetic ilo befirstphaseoftheGene-Tc Programselcted
assaysystemsforevaluation, generatedexpertpanelrevewsofthedatafromthescientificliterature, andrecommend-
edtestingprotocolsforthesystems. PhaseI estaldandevaluatedthedatabaseofchemicalgenetictoxicity datafor
itsrelvance toidentifying humanhealth ha . Theongoingphasemcontinues evieWi adupdating chemial data
inselectedassaysystems. Currently, dataexistonover400ch0 mcals in27assaysystems; twoadditionalassaysystems
wili beincludedinphasem.Thereviewdataarep intheselentficlteratureandarealsopubliclyavaiablethrough
theNationalLibraryofMedicine NE system.ThervewandanaaIscomponentsofGene-Toccomprise45published
papers, andseveralothersareinpreparation. Differencesthathave beenobservedbetweenGene-ToxandNationalTox-
icologyProgramdatabasesrelativetothesensitivity,specificity,accuracy,andpredictivityofgenetictoxicity datacom-
paredtocarcinogenesisdataareascribable todifferencesbetweenthetwodataesinchemicalselectioncriteria,testing
protocols, andchemicalclass distributions.
Introduction
TheU.S. EnvironmentalProtectionAgency'sGene-ToxPro-
gram isamultiphasedefforttoreviewandevaluatetheexisting
literature in genetic toxicology. Phase I of the program was
devotedtotheselectionofassaystobeevaluatedandtheevalua-
tionofliterature by workgroupsofexperts ineacharea. Phase
IIwasdevotedtoestablishing adatabaseofchemicalsevaluated
byeachworkgroupandanalyzingthatdatabase. Phasem(ongo-
ingefforts)isdevotedtothecontinuedreviewofselectedassays
andupdatingofthedatabase, nowpubliclyavailable iroughthe
NationalLibraryofMedicine(NLM)TOXNETsystem. Reports
ofallthreephasesarepublishedinMutationResearchReviews
in Genetic Toxicology (1-4).
Phase I
During phase I ofthe program, work groups ofexperts re-
viewed and evaluated the published literature for 23 selected
assays (Table 1) to determine a) the validity of a particular
system, b)thechemicals forwhichitwasbestsuited, c)thepro-
per test protocol, and c) the appropriate techniques of data
analysis, interpretation, andpresentation.
In addition, each work group was asked to a) evaluate the
assay's ability to discriminate between mutagens and non-
mutagens and/orcarcinogens andnoncarcinogens, b) evaluate
Table 1. Assaysevaluatedin phase I.
Gene mutation
Chromosomal effects
DNA damageand
repair
Oncogenic
transformation
Ancillary assays
Salmonella typhimurium'
Escherichia coli
Yeast
Fungi
Plants
Chinese hamsterlung cells (V79)'
Chinesehamsterovary cells (CHO)'
Mouse lymphoma L5178Y cells'
Mouse spottest
Mouse visible specific locus test'
Mammaliancytogenetics'
Plantcytogenetics'
Sisterchromatidexchange'
Yeast
Fungi
Drosophila
Dominant lethalassay'
Micronucleusassay'
Mouseheritable translocation assay'
Repair-proficient and -deficient bacteria
Unscheduled DNA synthesis'
DNA repair
Cell strains
Cell lines
Viral enhancement
Host-mediated assay/body fluidanalysis
Spermmorphology
'Assay selected for update.
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thesystem'sperformancewithchemicalsofvariousclassesand
identifychemicalswhoseeffectswerenotadequatelydetected,
c) formulategeneralizedprotocols andcriteriafordataevalua-
tion and validation, d) identify areas requiring additional
researchorfurtherdevelopmentandvalidation, ande)publish
anevaluation ofthe assay inthe openliterature.AULETTA ETAL.
Literature forevaluation wasprovided tothe workgroupsby
the Environmental Mutagen Information Center (EMIC), Oak
Ridge National Laboratory, Oak Ridge, Tennessee. EMIC
selectedonlythatportionoftheavailableliteraturewhichmetthe
following criteria: thearticle wasaprimary paperpublished in
apeer-reviewedjournal, itdealtwithchemical mutagenesis, the
agent studied was a purechemical, the article contained quan-
titative data, and the article was published in English or a
language for which EMIC had easy access to a translation.
Articles thatmetthesecriteriaweregiventotheworkgroups,
whichthenevaluatedeacharticleforthefollowingelements: pro-
peruseofexperimental design; useofpositiveandnegativecon-
trols; properselectionofsolvents andvehicles; acceptablespon-
taneousbackground mutationfrequency orrate; useofmetabolic
activation systems, ifnecessary; useofappropriatecriteria; for
positive, negative, or inconclusive results; and provision of
dose-response information. This latter criterion was not con-
sidered critical ifall others were met. In addition, each work
groupwasfreetoapplyothercriteriathatmightbespecific toits
particular assay. Agents evaluated were designated as positive
(+), positivewithdose-response dataprovided (+D), positive
with activation only (+*), negative (-), or evaluated but no
definitive call possible (T).
AttheendofphaseI, theworkgroupshadpublished37review
articles, 36 concerned with assays in genetic toxicology and 1
describing the establishment ofthe Gene-Tox carcinogen data-
base (2).
beentested inonly one system. Thosechemicals thathadbeen
tested in more than one system were, for the most part, either
direct-acting mutagens orthosethatareknown to metabolize to
reactive intermediates by liverenzyme systems. This may have
made sensitivity ofthevarious systemsappearunnaturally high.
Thedatabase is skewedtothepositive. Withtheexception of
the Salmonella assay there is a paucity ofnegative data in the
database ingeneralandinthecarcinogendatabaseinparticular,
whereonly 61 of506chemicalsevaluated had negative results.
Chemicalstestedareunevenlydistributedacrossthe30classes
used intheGene-Toxclassification scheme(Table3). The most
heavily tested classes are class 25, benzene rings; class 30,
heterocyclic rings not otherwise classified, unclassified com-
pounds; class29, alcoholsandphenols;class8, aromaticamines,
aliphaticamines, amides, andsulfonamides; andclass2, acyland
arylhalides, halogenatedethersandhalohydrins, and saturated
and unsaturated alkyl halides. Such a distribution makes an
analysis ofchemical class specificity ofthe various assays dif-
ficult for all except the Salmonella assay, where a sufficient
number ofchemicals have been tested in the various classes to
permit a determination of system performance according to
chemical class.
ThephaseIIanalysisresultedinthreepublications; onedeal-
ingwiththeestablishmentofthedatabase(1), onedealingwith
theevaluationofmutagenicity assaysforthepurposeofgenetic
riskassessment (3), andathirddealingwiththedevelopmental
status ofvarious assays for genetic toxicology testing (4).
Phase 11
In addition to the published reports, a database ofmore than
2000chemicalshadbeenestablishedatEMIC (3). Attheoutset
ofthe Gene-Tox Program, it was anticipated that this database
would be amenable to the type ofanalysis that would answer a
seriesoffundamental questions aboutgenetictoxicology (Table
2). However, certain characteristics ofthedatabase have made
such an analysis difficult, ifnot impossible, to perform.
Chemicalsareunevenlydistributedacrossassaysystems. For
example, of the more than 1000 chemicals in the phase I
Salmonella database, approximately 200 had been tested in a
cancer bioassay. In comparison, 59 ofthe approximately 200
chemicals inthemouselymphomaL5178YphaseIdatabasehad
been tested in abioassay.
There is littlebasis for studiesofcomparative mutagenesis. In
the phase I database, 1559 chemicals, or 59% ofthe total, had
Table 2. Goals ofphase II ofthe Gene-Tox Program.
Identify genetic and related endpoints that are ofconcern to human health
Distinguish those systems that are most ready for extensive use in testing
from those that should be regarded as developmental
Determine the sensitivity ofeach assay to respond to specific classes of
chemicals and identify major strengths and weaknesses
Examine the qualitative correlation between mutagenesis and carcinogenesis
end points
Devise specialized batteries ofbioassays that detect with high probability the
various types ofgenetic and related damage induced by various classes of
chemicals
Consider the potential utility ofin Witro mutagenesis and carcinogenesis
bioassays for potency estimation
Identify information gaps and future research needs and establish a
mechanism for evaluating the status oftest systems on a continuing basis
Table 3. Gene-Toxchemical classification scheme.
1. Acridines, quinacridines, benzimidazoles
2. Acyl andaryl halides, halogenated ethers and halohydrins, saturated
and unsaturated alkyl halides
3. Aldehydes, anhydrides
4. Alkyl epoxides, aryl epoxides
5. Alkyl sulfates, sulfoxides, sulfones, sulfonates, organic sulfur com-
pounds not otherwise classified
6. Anthraquinones, quinones
7. Antibiotics, mycotoxins
8. Aromatic amines, aliphatic amines, amides and sulfonamides
9. Aziridines, nitrogen and sulfur mustards
10. Aromatic azo compounds, azoxy compounds, hydrazo compounds,
diazoalkanes, nitriles, azides
11. Carbamates, ureas, thioureas, dicarboximides
12. Dioxins, xanthenes, thioxanthenes, phenothiazines
13. Halogens and inorganic derivatives, sulfur and nitrogen oxides
14. Hydrazides, hydrazines, triazenes
15. Hydroxylamines, amine-N-oxides
16. Lactones, organic peroxides
17. Mineral fibers
18. Nitroimidazoles, nitrofurans, nitroquinolines, nitroaromatics,
nitroalkanes
19. Nitrosamides, nitrosoureas, nitrosoguanidines
20. Nitrosamines
21. Organolead, organomercury, organophosphorus compounds, metals
and derivatives, phosphoric acid esters, and phosphamides
22. Polycyclic aromatic hydrocarbons, fluorenones
23. Pyrimidine derivatives, purine derivatives
24. Steroids
25. Benzene ring
26. Amino acids and derivatives
27. Alkaloids
28. Carbohydrates and derivatives
29. Alcohols and phenols
30. Heterocyclic rings not otherwise classified, unclassified compounds
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Phase III
As part ofthe ongoing Gene-Tox effort, certain assays from
phaseIhavebeen selectedforupdate (Table 1). Inaddition, two
assays not evaluated in phase I, the Chinese hamster ovary
(CHO) AS52 assay and the mouse biochemical specific locus
assay, will be included inthe updateddatabase.
Althoughtheupdate processhasbeensimplified overthatused
in phase I, the overall objectives ofthe program and the basic
work group structureremaininplace. More than 1500chemicals
havebeenaddedtothedatabasesincethecompletionofphase I,
bringing to over4000thetotal numberofchemicals evaluated.
Thebasic featuresofthephaseHI database arethe same asthose
notedabove lbrphase I. There isstill apaucityofnegativedata;
themajorityofthechemicalsevaluatedhavebeentestedinonly
one system and chemical class distribution is essentially un-
affected.
The database for the Salmonella assay now totals 2469
chemicals. Ofthese, 1100arepositive, 880 arenegativeand489
areclassified as T. Ofthe 1100chemicals that arepositive, 666
arepositive without activation, 416 arepositive withactivation,
and 18 arepositive withoutactivationand negativewith activa-
tion (Table 4).
Of the 2469 chemicals in the Salmonella subset, 328 have
associated carcinogenicity data, 268 are classified as carcino-
gens, and58 areclassified asnoncarcinogens. Twohundredten
of the 268 carcinogens are positive in Salmonella; 58 are
negative. Of the 58 noncarcinogens, 38 are negative in
Salmonella; 20 are positive. Sensitivity is 78%, specificity is
65%, accuracy (concordance) is 76%. Positive predictivity is
91%, negativepredictivity is39%. Zeigeretal. (5), reporting on
results ofthe National Toxicology Program (NTP) testing in-
itiative with 114 chemicals, reported 52% sensitivity, 91%
specificity, 62% concordance, 90% positive predictivity, and
55% negative predictivity for the Salmonella assay (Table 5).
TheGene-Tox and NTPdatabases aredifferentinseveral im-
portant aspects. Most notably, chemicals in the NTP were
selected according to defined criteria and tested according to
standard protocols, whereas chemical selection inGene-Tox is
random, andprotocols arevaried. Inthe caseoftheSalmonella
assay, however, the most likely reason for the reported dif-
ferences insensitivity, specificity, predictiveability, and concor-
danceoftheassay isprobablyrelatedtochemicalclassdistribu-
tion ofthe agents tested.
The Gene-Tox chemical classification scheme is based on
selected organic functional groups, ring systems, biological
origins, and/ororganiccomposition. Carcinogensthat havebeen
tested in the Salmonella assay are more apt to be classified as
halides, epoxides, sulfurcompounds, mustards, xanthenes, nitro
and nitroso compounds, nitrosamines, metals, polycyclic
aromatic hydrocarbons (PAH), steroids, and benzene rings.
Table4. The Gene-Tox Salmonella database.
Total number evaluated 2469
Positive 1100
Positive without activation 666
Positive with activation 416
Positive without activation, negative with 18
Negative 880
Nodefinite call 489
Falsepositiveresultsaredistributedacrossthedatabaseinthe
following pattern: alkyl halides, 12; vinyl/allyl compounds 6;
halogenated benzenes, benzeneamines and steroids, 5 each;
metals and aromatic azides, 4 each; benzene/phenols and
ureas/carbamates, 3 each; amides andhydrazines, 2 each; and
miscellaneous, 1.
Distributionofthefirstsetof73NTPchemicals(6)acrossthe
Gene-Toxchemicalclassification schemeshowsarelativelyhigh
number of agents classified as alkyl halides, allyl and vinyl
alkenes, benzeneamines, andaromaticazocompounds; thesame
classesinwhichGene-Toxhasfoundahighproportionoffalse
negative responses. Ifthis distributionholds true for the com-
bined set of 114 chemicals, it could account for the lower sen-
sitivity observed by the NTP and accordingly the differences
noted in theotherparameters.
Noncarcinogens in the Gene-Tox Salmonella database are
foundprimarily inclasses 2 (halides), 8 (aromaticamines), 11
Table5. Comparison oftheGene-Toxand Salmonella databases.
Accuracy Positive Negative
(concor- predic- predic-
Database Sensitivity Specificity dance) tivity tivity
Gene-Tox 210/268 38/58 248/326 210/230 38/96
78% 65% 76% 91% 39%
NTPr 35/67 43/47 75/114 35/39 43/78
52% 91% 66% 90% 55%
'From Zeigeret al. (5).
0. ** ADMINISTRATIVE INFORMATION
GTN GENE-TOX Number (Sequential Order)
DATE Last Revision Date
RLEN Record Length
UPDT Update History
1. ID ** SUBSTANCE IDENTIFICATION
NAME Name of Substance
RN CAS Registry Number
SY Synonyms
CCAT Chemical Classification Category
2. MSTU ** MUTAGENICITY STUDIES
GENB GENE-TOX Evaluation B (Post 1980)
(Species/Cell Type] (Sex]
[Assay Type]
[Assay Code]
(Results]
(Activation]
[Dose Response]
[Reference]
[Panel Report]
GENA GENE-TOX Evaluation A (Pre 1980)
(Species/Cell Type]
[Sex]
(Assay Type]
[Assay Code]
(Results]
[Activation]
[Dose Response]
[Reference]
[Panel Report]
FIGURE 1. TOXNETGene-Tox unit record.
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GTN - 14
UPDT - Complete Update on 11/21/90, 6 Fields
Added/Edited/Deleted
RLEN - 1593
NAME - FORMALDEHYDE
RN - 50-00-0
GENB
SPECIES/CELL TYPE : Chinese hamster ovary (CHO)
cells
ASSAY TYPE : Gene mutation at the HGPRT
locus
ASSAY CODE : CHOT
RESULTS : No conclusion
REFERENCE : EMIC/53976; J TOXICOL
ENVIRON HEALTH 12:27-38,
1983
PANEL REPORT : EMIC/71517; MUTAT RES
196:17-36, 1988
GENB
SPECIES/CELL TYPE : Mammalian polychromatic
erythrocytes, all species
ASSAY : Micronucleus test
ASSAY CODE : MNTT
RESULTS : No conclusion
REFERENCE : EMIC/41641; MUTAT RES 90:91-
109, 1981
PANEL REPORT : EMIC/77345; MUTAT RES
239:29-80,1990
GENA
SPECIES/CELL TYPE : Neurospora crassa
ASSAY TYPE : Reverse mutation
ASSAY CODE : NER+
RESULTS : Positive
PANEL REPORT : EMIC/52327; MUTAT RES
133:87-134, 1984
FIGURE 2. Gene-Tox unit record for formaldehyde.
(carbamates and ureas), 18 (nitro compounds), 22 (PAH), and
25 (benzene rings). It appears from this analysis that the
Salmonellaassaycanserveasausefultoolforidentifyingin vivo
carcinogens, providing attention is paid to the importance of
chemical class when interpreting results.
TheGene-Tox databaseisnowpublicly availablethroughthe
National LibraryofMedicine'sTOXNETsystem. The'TOXNET
unitrecordfortheGene-ToxdatabaseisshowninFigure 1; apar-
tial recordforformaldehyde is showninFigure2. Updateofthe
database nowthatitispublicwillbeprimarily theresponsibility
oftheEPAwiththeassistanceofEMIC. Theupdatewillcontinue
to make use ofthe peer-review system although in a slightly
modified form. Chemicals to be added to the database will be
published in a series of short papers in Mutation Research
Reviewsin Genetic Toxicology; simultaneously with submission
ofthemanuscript,thechemicalsevaluatedforeachassaywillbe
addedto thepublicly availabledatabase. Atpresent, theTOX-
NETdatabasecontainsallofthosechemicalsevaluatedinphase
I and results ofthe update forthe CHO/HGPRT assay and the
micronucleus assay.
The EPA wishes to take this opportunity to express its gratitude to those
membersofthegenetictoxicologycommunity whohavegiven sogenerously of
theirtimeandtalent tocontribute tothe successofthe program. We alsothank
thestaffofEMICfortheirunfailing supportwithoutwhichthisprogram would
not be possible.
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